Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Neil Aggarwal

Concepts (338)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oxygen
11
2026
998
2.520
 Why?
Outpatients
5
2024
450
1.910
 Why?
Antiviral Agents
6
2026
776
1.660
 Why?
Hypoxia
8
2026
1208
1.250
 Why?
Acute Lung Injury
11
2015
312
1.170
 Why?
Adenosine Monophosphate
4
2026
88
1.160
 Why?
Macrophages, Alveolar
5
2016
377
1.140
 Why?
Alanine
3
2025
173
1.080
 Why?
Oxygen Inhalation Therapy
5
2026
190
1.020
 Why?
Pneumonia
7
2025
636
0.980
 Why?
Intensive Care Units
5
2026
928
0.900
 Why?
Hospitalization
10
2026
2496
0.900
 Why?
Respiration, Artificial
4
2026
717
0.850
 Why?
Hyperoxia
1
2026
127
0.830
 Why?
T-Lymphocytes, Regulatory
5
2015
415
0.780
 Why?
Interleukin-6
4
2026
784
0.760
 Why?
Critical Illness
8
2026
907
0.750
 Why?
National Heart, Lung, and Blood Institute (U.S.)
6
2021
103
0.670
 Why?
Respiratory Insufficiency
4
2026
330
0.650
 Why?
Intubation, Intratracheal
3
2026
329
0.540
 Why?
Phagocytes
1
2018
80
0.510
 Why?
Positive-Pressure Respiration
1
2018
116
0.500
 Why?
Lung Injury
3
2026
262
0.490
 Why?
Smoke
1
2016
148
0.430
 Why?
Leukocytes, Mononuclear
1
2018
590
0.430
 Why?
Lung
12
2018
4141
0.420
 Why?
Adult
25
2026
41405
0.400
 Why?
Receptor, Adenosine A2A
1
2013
23
0.380
 Why?
Lipopolysaccharides
9
2015
863
0.360
 Why?
Aged
21
2026
26514
0.350
 Why?
Immunity, Innate
1
2018
840
0.350
 Why?
Antibodies, Viral
3
2024
687
0.340
 Why?
Humans
53
2026
147293
0.340
 Why?
Multicenter Studies as Topic
4
2026
417
0.330
 Why?
Antibodies, Monoclonal
5
2024
1514
0.320
 Why?
Bacteria
1
2016
769
0.320
 Why?
Hydroxychloroquine
2
2020
65
0.310
 Why?
Smoking
2
2016
1483
0.300
 Why?
Male
36
2026
73950
0.300
 Why?
Mice, Inbred C57BL
16
2025
6041
0.300
 Why?
Middle Aged
21
2026
36821
0.300
 Why?
Research Report
2
2021
89
0.290
 Why?
Bronchoalveolar Lavage Fluid
7
2013
641
0.270
 Why?
Macrophages
1
2016
1529
0.270
 Why?
Flow Cytometry
3
2018
1172
0.260
 Why?
Inflammation Mediators
4
2016
507
0.250
 Why?
Epithelial Cells
4
2016
1141
0.250
 Why?
Vaccination
2
2024
1443
0.250
 Why?
Wound Healing
1
2009
361
0.250
 Why?
Mice
15
2025
18491
0.240
 Why?
Neuromuscular Nondepolarizing Agents
1
2026
34
0.240
 Why?
Androstanols
1
2026
30
0.240
 Why?
Mice, Knockout
8
2015
3153
0.230
 Why?
Immunophenotyping
2
2018
325
0.230
 Why?
Carotid Artery, Internal
1
2006
45
0.230
 Why?
Antibodies, Neutralizing
3
2023
345
0.230
 Why?
Etomidate
1
2025
21
0.230
 Why?
Hospitals, Community
1
2026
67
0.230
 Why?
Colorado
3
2025
4591
0.230
 Why?
Pragmatic Clinical Trials as Topic
1
2026
134
0.230
 Why?
Utah
1
2025
83
0.230
 Why?
Carotid Artery Diseases
1
2006
70
0.230
 Why?
Critical Care
2
2024
705
0.220
 Why?
Phagocytosis
2
2018
299
0.220
 Why?
Randomized Controlled Trials as Topic
4
2026
1776
0.220
 Why?
Sepsis
2
2024
671
0.220
 Why?
Lymphopenia
1
2025
62
0.210
 Why?
Intracranial Aneurysm
1
2006
106
0.210
 Why?
Animals
19
2025
38410
0.210
 Why?
Health Care Rationing
1
2024
56
0.200
 Why?
Ketamine
1
2025
141
0.200
 Why?
Organ Dysfunction Scores
1
2024
55
0.200
 Why?
Female
22
2026
80076
0.200
 Why?
Hospital Mortality
2
2025
1043
0.200
 Why?
Multiple Organ Failure
1
2024
122
0.200
 Why?
Lung Diseases
2
2021
787
0.200
 Why?
Antigens, Viral
1
2024
186
0.190
 Why?
Noninvasive Ventilation
1
2024
63
0.190
 Why?
Biomedical Research
2
2021
723
0.190
 Why?
Research Design
2
2026
1157
0.190
 Why?
Analgesics, Non-Narcotic
1
2024
131
0.190
 Why?
Public-Private Sector Partnerships
2
2021
44
0.190
 Why?
Gene Expression Profiling
1
2009
1794
0.180
 Why?
Sleep Deprivation
1
2025
207
0.180
 Why?
Ritonavir
1
2023
76
0.180
 Why?
Polycystic Kidney, Autosomal Dominant
1
2006
244
0.180
 Why?
Pulmonary Circulation
2
2021
434
0.180
 Why?
Proportional Hazards Models
1
2025
1344
0.180
 Why?
Acetaminophen
1
2024
269
0.170
 Why?
Cytokines
3
2016
2086
0.170
 Why?
Pandemics
4
2026
1720
0.170
 Why?
Retrospective Studies
6
2025
17560
0.170
 Why?
Cell Membrane Permeability
2
2012
89
0.160
 Why?
Education
1
2021
106
0.160
 Why?
Electronic Health Records
2
2026
1214
0.160
 Why?
RNA, Viral
1
2024
695
0.160
 Why?
Pulmonary Alveoli
3
2015
389
0.150
 Why?
Tidal Volume
2
2018
109
0.150
 Why?
Triglycerides
2
2013
529
0.150
 Why?
Neutrophils
4
2015
1135
0.150
 Why?
Antibodies
1
2021
398
0.150
 Why?
Disease Models, Animal
6
2025
4604
0.140
 Why?
Serum Bactericidal Test
1
2018
1
0.140
 Why?
Financing, Government
1
2019
53
0.140
 Why?
Ventricular Function, Right
1
2021
300
0.140
 Why?
Machine Learning
1
2024
596
0.140
 Why?
United States
11
2026
16313
0.140
 Why?
Interinstitutional Relations
1
2018
56
0.140
 Why?
Rare Diseases
1
2019
116
0.140
 Why?
Partial Pressure
1
2018
30
0.140
 Why?
Vascular Diseases
1
2021
252
0.140
 Why?
Severity of Illness Index
3
2025
2973
0.140
 Why?
APACHE
1
2018
68
0.130
 Why?
Blood Gas Analysis
1
2018
82
0.130
 Why?
Treatment Outcome
8
2026
11947
0.130
 Why?
Systemic Inflammatory Response Syndrome
1
2018
96
0.130
 Why?
Streptococcus
1
2018
29
0.130
 Why?
Betacoronavirus
1
2020
288
0.130
 Why?
Biomarkers
4
2026
4351
0.130
 Why?
Precision Medicine
1
2021
464
0.120
 Why?
Endothelial Cells
2
2016
886
0.120
 Why?
Cell Separation
1
2018
306
0.120
 Why?
Macrophage Activation
1
2018
181
0.120
 Why?
Adoptive Transfer
3
2015
200
0.120
 Why?
Disease Susceptibility
1
2018
347
0.120
 Why?
Soot
1
2016
23
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2022
1005
0.120
 Why?
Goals
1
2018
186
0.120
 Why?
Chemokines
2
2015
217
0.110
 Why?
Research
1
2019
434
0.110
 Why?
Leukocytosis
1
2015
32
0.110
 Why?
DNA Modification Methylases
1
2015
19
0.110
 Why?
Pneumonia, Viral
1
2020
387
0.110
 Why?
Wasting Syndrome
1
2015
12
0.110
 Why?
Coronavirus Infections
1
2020
378
0.110
 Why?
Nitric Oxide Synthase Type II
2
2012
162
0.110
 Why?
Muscular Atrophy
2
2015
87
0.110
 Why?
Epithelium
1
2016
311
0.110
 Why?
Lung Transplantation
1
2018
338
0.110
 Why?
Interview, Psychological
1
2015
95
0.110
 Why?
Interleukin-10
2
2014
311
0.110
 Why?
Lipoprotein Lipase
2
2013
56
0.100
 Why?
Air Pollution, Indoor
1
2016
171
0.100
 Why?
Tissue and Organ Procurement
1
2018
350
0.100
 Why?
Ubiquitin-Protein Ligases
2
2015
199
0.100
 Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2015
232
0.100
 Why?
Muscle Proteins
2
2015
244
0.100
 Why?
Societies, Medical
1
2018
914
0.100
 Why?
Azacitidine
1
2015
168
0.100
 Why?
Cells, Cultured
4
2016
4169
0.100
 Why?
Lipoproteins
2
2013
166
0.100
 Why?
Particulate Matter
1
2016
329
0.100
 Why?
Phenethylamines
1
2013
16
0.100
 Why?
Osteomyelitis
1
2015
146
0.100
 Why?
Adenosine A2 Receptor Agonists
1
2013
24
0.100
 Why?
Forkhead Transcription Factors
2
2015
210
0.090
 Why?
Bacteremia
1
2015
222
0.090
 Why?
Gene Knockout Techniques
1
2013
122
0.090
 Why?
Physical Conditioning, Animal
1
2015
242
0.090
 Why?
Aquaporin 5
1
2012
3
0.090
 Why?
Adaptive Clinical Trials as Topic
2
2022
24
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
980
0.090
 Why?
Air Pollutants
1
2016
407
0.090
 Why?
Pulmonary Disease, Chronic Obstructive
2
2016
928
0.090
 Why?
Enzyme Inhibitors
1
2015
822
0.090
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 2
1
2011
1
0.090
 Why?
Adenosine
1
2013
255
0.080
 Why?
Capillary Permeability
1
2011
132
0.080
 Why?
Time Factors
5
2016
7173
0.080
 Why?
Staphylococcal Infections
1
2015
395
0.080
 Why?
Aftercare
2
2023
225
0.080
 Why?
Heart Arrest
2
2025
412
0.080
 Why?
Treatment Failure
2
2022
360
0.080
 Why?
Double-Blind Method
2
2026
2080
0.080
 Why?
Longitudinal Studies
1
2018
3027
0.080
 Why?
Genes, RAG-1
1
2009
11
0.080
 Why?
Family
1
2015
690
0.080
 Why?
Microtubules
1
2012
267
0.080
 Why?
Exercise Therapy
1
2015
489
0.080
 Why?
Leukocyte Reduction Procedures
1
2009
29
0.080
 Why?
HIV-1
1
2016
917
0.070
 Why?
Hypertension, Pulmonary
1
2021
1977
0.070
 Why?
Monocytes
1
2012
539
0.070
 Why?
Interleukin-2 Receptor alpha Subunit
1
2009
84
0.070
 Why?
Dose-Response Relationship, Drug
2
2026
2030
0.070
 Why?
Phenotype
3
2026
3216
0.070
 Why?
Leukocyte Count
1
2009
319
0.070
 Why?
Cluster Analysis
1
2009
502
0.070
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
751
0.070
 Why?
Heart Failure
1
2021
2334
0.070
 Why?
Muscle, Skeletal
2
2015
1798
0.060
 Why?
Gene Regulatory Networks
1
2009
318
0.060
 Why?
T-Lymphocyte Subsets
1
2009
421
0.060
 Why?
Prospective Studies
4
2026
8164
0.060
 Why?
Cohort Studies
3
2024
6099
0.060
 Why?
Sleep Apnea, Obstructive
1
2011
303
0.060
 Why?
Adipose Tissue
1
2011
646
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2026
31
0.060
 Why?
Triazines
1
2026
49
0.060
 Why?
Receptor for Advanced Glycation End Products
1
2026
36
0.060
 Why?
Indazoles
1
2026
86
0.060
 Why?
Patient Discharge
2
2023
1002
0.060
 Why?
Mental Disorders
1
2015
1188
0.060
 Why?
Anesthetics, Dissociative
1
2025
47
0.060
 Why?
Anesthetics, Intravenous
1
2025
69
0.060
 Why?
Oximetry
1
2026
125
0.050
 Why?
Triazoles
1
2026
191
0.050
 Why?
Lymphocyte Count
1
2025
165
0.050
 Why?
Homeodomain Proteins
3
2015
525
0.050
 Why?
Gene Expression Regulation
2
2012
2625
0.050
 Why?
Receptors, CXCR4
2
2016
91
0.050
 Why?
Data Interpretation, Statistical
1
2026
369
0.050
 Why?
C-Reactive Protein
1
2026
430
0.050
 Why?
Phentolamine
1
2023
19
0.050
 Why?
Masks
1
2024
70
0.050
 Why?
Tripartite Motif Proteins
2
2015
39
0.050
 Why?
Vasoactive Intestinal Peptide
1
2023
20
0.050
 Why?
Renal Replacement Therapy
1
2024
104
0.050
 Why?
United States Food and Drug Administration
1
2024
208
0.050
 Why?
Acute Disease
1
2026
1049
0.050
 Why?
Tomography, X-Ray Computed
2
2006
2791
0.050
 Why?
Infusions, Intravenous
1
2024
430
0.050
 Why?
Sensitivity and Specificity
3
2018
2017
0.050
 Why?
Streptococcus pneumoniae
1
2025
190
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2009
1162
0.050
 Why?
Nucleocapsid
1
2022
19
0.050
 Why?
Angiopoietins
2
2013
12
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2022
75
0.050
 Why?
Cell Line, Transformed
2
2012
138
0.040
 Why?
Drug Combinations
1
2023
399
0.040
 Why?
Hemoglobins
1
2024
386
0.040
 Why?
Epigenomics
1
2022
125
0.040
 Why?
Granulomatosis with Polyangiitis
1
2002
47
0.040
 Why?
Blotting, Western
2
2016
1186
0.040
 Why?
Electroencephalography
1
2025
570
0.040
 Why?
Feasibility Studies
1
2026
1147
0.040
 Why?
Health Policy
1
2024
405
0.040
 Why?
Review Literature as Topic
1
2021
53
0.040
 Why?
Random Allocation
2
2012
366
0.040
 Why?
National Institutes of Health (U.S.)
1
2021
149
0.040
 Why?
Macrophages, Peritoneal
2
2012
89
0.040
 Why?
User-Computer Interface
1
2002
165
0.040
 Why?
Bronchoscopy
1
2002
228
0.040
 Why?
Drug Discovery
1
2021
153
0.040
 Why?
Antimalarials
1
2020
35
0.040
 Why?
HIV Infections
1
2016
3235
0.040
 Why?
Bayes Theorem
1
2022
428
0.040
 Why?
Airway Obstruction
1
2002
153
0.040
 Why?
Single-Blind Method
1
2020
319
0.040
 Why?
Netherlands
1
2018
85
0.030
 Why?
Case-Control Studies
1
2026
3660
0.030
 Why?
Ventricular Dysfunction, Right
1
2021
248
0.030
 Why?
Disease Progression
1
2026
2890
0.030
 Why?
Sleep
1
2025
895
0.030
 Why?
Epigenesis, Genetic
1
2022
708
0.030
 Why?
Prognosis
1
2026
4383
0.030
 Why?
Image Processing, Computer-Assisted
1
2002
794
0.030
 Why?
Wounds and Injuries
1
2026
977
0.030
 Why?
Clinical Trials as Topic
1
2022
1072
0.030
 Why?
Inflammation
3
2015
2920
0.030
 Why?
Congresses as Topic
1
2018
226
0.030
 Why?
ROC Curve
1
2018
626
0.030
 Why?
Computational Biology
1
2021
677
0.030
 Why?
Bacterial Infections
1
2018
247
0.030
 Why?
Risk Factors
2
2022
11017
0.030
 Why?
Virus Diseases
1
2018
218
0.030
 Why?
Graft Survival
1
2018
534
0.030
 Why?
Intercellular Adhesion Molecule-1
1
2016
132
0.030
 Why?
Cell Count
1
2016
321
0.030
 Why?
Cognition
1
2024
1286
0.030
 Why?
Receptors, Granulocyte Colony-Stimulating Factor
1
2015
1
0.030
 Why?
Ethnopsychology
1
2015
6
0.030
 Why?
Cooperative Behavior
1
2018
471
0.030
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
174
0.030
 Why?
Chemotaxis, Leukocyte
1
2015
115
0.030
 Why?
Microscopy, Confocal
1
2016
322
0.030
 Why?
Granulocyte Colony-Stimulating Factor
1
2015
90
0.030
 Why?
Cross-Cultural Comparison
1
2015
84
0.030
 Why?
Sputum
1
2016
302
0.030
 Why?
Respiratory Function Tests
1
2016
545
0.030
 Why?
Cadherins
1
2016
204
0.030
 Why?
Diagnosis, Differential
1
2018
1518
0.030
 Why?
Cell Lineage
1
2016
381
0.030
 Why?
Immunocompromised Host
1
2015
202
0.030
 Why?
Emergency Service, Hospital
1
2026
2416
0.020
 Why?
Environmental Monitoring
1
2016
347
0.020
 Why?
Influenza A Virus, H1N1 Subtype
1
2015
162
0.020
 Why?
Magnetic Resonance Imaging
1
2006
3980
0.020
 Why?
Adipose Tissue, White
1
2013
43
0.020
 Why?
Benzylamines
1
2012
44
0.020
 Why?
Mice, Congenic
1
2012
23
0.020
 Why?
B7-2 Antigen
1
2012
27
0.020
 Why?
Cell Survival
1
2016
1111
0.020
 Why?
Host-Pathogen Interactions
1
2016
366
0.020
 Why?
Heterocyclic Compounds
1
2012
23
0.020
 Why?
Adipose Tissue, Brown
1
2013
60
0.020
 Why?
RING Finger Domains
1
2012
4
0.020
 Why?
Chemokine CXCL12
1
2012
86
0.020
 Why?
Diet, Atherogenic
1
2011
6
0.020
 Why?
Chylomicrons
1
2011
18
0.020
 Why?
Lipoproteins, VLDL
1
2011
21
0.020
 Why?
Ventilators, Mechanical
1
2011
71
0.020
 Why?
Cyclic GMP
1
2011
90
0.020
 Why?
Myofibroblasts
1
2012
149
0.020
 Why?
Gene Expression
1
2016
1481
0.020
 Why?
Cross-Sectional Studies
1
2022
6011
0.020
 Why?
Cyclic AMP
1
2011
208
0.020
 Why?
Ventilator-Induced Lung Injury
1
2011
61
0.020
 Why?
Adenoviridae
1
2011
199
0.020
 Why?
Quality of Life
1
2023
3246
0.020
 Why?
Motor Activity
1
2015
719
0.020
 Why?
Down-Regulation
1
2012
618
0.020
 Why?
Trachea
1
2011
258
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2011
552
0.020
 Why?
Obesity
1
2022
3149
0.020
 Why?
Muscle Strength
1
2012
336
0.020
 Why?
Cardiovascular Diseases
1
2021
2218
0.020
 Why?
RNA, Small Interfering
1
2011
643
0.020
 Why?
Risk Assessment
1
2018
3784
0.020
 Why?
Multivariate Analysis
1
2012
1550
0.020
 Why?
Immunohistochemistry
1
2012
1730
0.020
 Why?
Young Adult
1
2024
14437
0.020
 Why?
Fibroblasts
1
2012
1039
0.020
 Why?
Cell Line
1
2012
2832
0.020
 Why?
Aged, 80 and over
1
2018
8430
0.010
 Why?
Postoperative Complications
1
2018
3022
0.010
 Why?
Proteins
1
2011
1024
0.010
 Why?
Cell Proliferation
1
2012
2529
0.010
 Why?
Adolescent
1
2024
22825
0.010
 Why?
Survival Rate
1
2009
2110
0.010
 Why?
Anti-Bacterial Agents
1
2015
1940
0.010
 Why?
RNA, Messenger
1
2011
2812
0.010
 Why?
Bronchography
1
2002
10
0.010
 Why?
Tracheal Stenosis
1
2002
39
0.010
 Why?
Observer Variation
1
2002
358
0.010
 Why?
Blood Glucose
1
2011
2359
0.010
 Why?
Insulin
1
2011
2526
0.010
 Why?
Signal Transduction
1
2012
5272
0.010
 Why?
Aggarwal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (338) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)